Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis
Clinical trial NCT02994056 · COMPLETED
Trial details
- NCT number
- NCT02994056
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2018-09-25
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.